학술논문

Role of Coronary Artery Calcium Score of Zero and Other Negative Risk Markers for Cardiovascular Disease
Document Type
article
Source
Circulation. 133(9)
Subject
Epidemiology
Biomedical and Clinical Sciences
Health Sciences
Atherosclerosis
Aging
Heart Disease
Prevention
Heart Disease - Coronary Heart Disease
Cardiovascular
Clinical Research
Good Health and Well Being
Aged
Biomarkers
C-Reactive Protein
Calcium
Cardiovascular Diseases
Cohort Studies
Coronary Vessels
Ethnicity
Female
Follow-Up Studies
Humans
Male
Middle Aged
Natriuretic Peptide
Brain
Peptide Fragments
Prospective Studies
Risk Factors
biomarkers
calcium
cardiac imaging techniques
cardiovascular diseases
risk assessment
Cardiorespiratory Medicine and Haematology
Clinical Sciences
Public Health and Health Services
Cardiovascular System & Hematology
Cardiovascular medicine and haematology
Clinical sciences
Sports science and exercise
Language
Abstract
BackgroundLimited attention has been paid to negative cardiovascular disease (CVD) risk markers despite their potential to improve medical decision making. We compared 13 negative risk markers using diagnostic likelihood ratios (DLRs), which model the change in risk for an individual after the result of an additional test.Methods and resultsWe examined 6814 participants from the Multi-Ethnic Study of Atherosclerosis. Coronary artery calcium score of 0, carotid intima-media thickness 5% change, ankle-brachial index >0.9 and 0.80. Among clinical features, absence of any family history of coronary heart disease was the strongest (DLRs, 0.76 [SD, 0.07] and 0.81 [SD, 0.06], respectively). Net reclassification improvement analyses yielded similar findings, with coronary artery calcium score of 0 resulting in the largest, most accurate downward risk reclassification.ConclusionsNegative results of atherosclerosis-imaging tests, particularly coronary artery calcium score of 0, resulted in the greatest downward shift in estimated CVD risk. These results may help guide discussions on the identification of individuals less likely to receive net benefit from lifelong preventive pharmacotherapy.